MAPT and ovarian cancer: For instance, in ovarian cancer, the down-regulation of Tau affected the viability of the high Tau-expressing TOV112V cell line while did not affect the low-Tau-expressing OVCAR cell line, suggesting a possible link with the microtubule composition and the level of Tau expression [91,106,108].